RecallDepth
Class II Completed

Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper bottle, NDC 60505-0564-1, UPC 3 60505 05641 5; b) 10 mL dropper bottle NDC 60505-0564-2, UPC 3 60505 05642 2; c) 15 mL dropper bottle, NDC 60505-0564-3, UPC 3 60505 05643 9; Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, FL 33326

Company
Apotex Corp.
Recall Initiated
March 1, 2023
Posted
March 15, 2023
Recall Number
D-0433-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
67,056 bottles
Firm Location
Weston, FL, United States

Reason for Recall

Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.

Distribution

Nationwide in the USA

Lot / Code Info

Lots: a) TJ9848 Exp. 02/2024, TJ9849 Exp. 02/2024, TK0258 Exp. 04/2024, TK5341 Exp. 04/2024; b) TK0261 Exp. 04/2024; c) TK0262 Exp. 04/2024

More recalls by Apotex Corp.

View all recalls by this company →

Other recent Class II Drug recalls